NOTVQ (Inotiv) Cyclically Adjusted Book per Share: $6.02 (As of Mar. 2026)


What is Inotiv Cyclically Adjusted Book per Share?

Inotiv NOTVQ -9.91% Cyclically Adjusted Book per Share is $6.02 as of Mar. 2026. The stock has 4 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Inotiv's adjusted book value per share for the three months ended in Mar. 2026 was $2.210. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $6.02 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Inotiv's average Cyclically Adjusted Book Growth Rate was 6.50% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 18.10% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 41.10% per year. During the past 10 years, the average Cyclically Adjusted Book Growth Rate was 11.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Inotiv was 56.90% per year. The lowest was -14.40% per year. And the median was -6.05% per year.

As of today (2026-06-24), Inotiv's current stock price is $0.01. Inotiv's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 was $6.02. Inotiv's Cyclically Adjusted PB Ratio of today is 0.00.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Inotiv was 41.34. The lowest was 0.01. And the median was 1.01.


Inotiv  (OTCPK:NOTVQ) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Inotiv's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=0.01/6.02
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Inotiv was 41.34. The lowest was 0.01. And the median was 1.01.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Inotiv Cyclically Adjusted Book per Share Related Terms


Inotiv Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Inotiv's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Inotiv Cyclically Adjusted Book per Share Chart

Inotiv Annual Data
Trend Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.40 3.56 4.64 5.41 5.86

Inotiv Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.65 5.76 5.86 5.89 6.02

NOTVQ vs NDRA, XWEL, ADVB: Cyclically Adjusted Book per Share Comparison

For the Diagnostics & Research subindustry, Inotiv's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Inotiv Cyclically Adjusted PB Ratio vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Inotiv's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Inotiv's Cyclically Adjusted PB Ratio falls into.



Inotiv Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Inotiv's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book= Book Value per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=2.21/330.2130*330.2130
=2.210

Current CPI (Mar. 2026) = 330.2130.

Inotiv Quarterly Data

Book Value per Share CPI Adj_Book
201606 1.022 241.018 1.400
201609 0.774 241.428 1.059
201612 0.780 241.432 1.067
201703 0.842 243.801 1.140
201706 0.873 244.955 1.177
201709 0.902 246.819 1.207
201712 0.909 246.524 1.218
201803 0.920 249.554 1.217
201806 0.976 251.989 1.279
201809 1.059 252.439 1.385
201812 1.046 251.233 1.375
201903 0.997 254.202 1.295
201906 0.981 256.143 1.265
201909 1.016 256.759 1.307
201912 0.957 256.974 1.230
202003 0.910 258.115 1.164
202006 0.839 257.797 1.075
202009 0.690 260.280 0.875
202012 0.668 260.474 0.847
202103 0.633 264.877 0.789
202106 5.602 271.696 6.809
202109 6.599 274.310 7.944
202112 24.273 278.802 28.749
202203 24.225 287.504 27.824
202206 24.055 296.311 26.807
202209 14.078 296.808 15.662
202212 10.966 296.797 12.201
202303 10.635 301.836 11.635
202306 10.707 305.109 11.588
202309 10.442 307.789 11.203
202312 9.855 306.746 10.609
202403 7.997 312.332 8.455
202406 7.002 314.175 7.359
202409 6.554 315.301 6.864
202412 5.037 315.605 5.270
202503 4.591 319.799 4.741
202506 4.185 322.561 4.284
202509 3.959 324.800 4.025
202512 3.170 324.054 3.230
202603 2.210 330.213 2.210

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of $6.02 mean?
Inotiv (NOTVQ) has a Cyclically Adjusted Book per Share of $6.02 as of Mar. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Inotiv and its competitors.
Is Inotiv's Cyclically Adjusted Book per Share too high?
Inotiv's current Cyclically Adjusted Book per Share is $6.02.
How does Inotiv's Cyclically Adjusted Book per Share compare to NDRA and XWEL?
Inotiv's Cyclically Adjusted Book per Share of $6.02 can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Medical Diagnostics & Research company?
A good Cyclically Adjusted Book per Share depends on the Medical Diagnostics & Research industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Inotiv and its competitors. Inotiv's current Cyclically Adjusted Book per Share is $6.02. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Inotiv stock overvalued right now?
Based on GuruFocus' analysis, Inotiv (NOTVQ) is currently considered Possible Value Trap. The stock's GF Value™ is $1.68, compared to a current price of $0.01 — trading 99.4% below its estimated fair value. The current Cyclically Adjusted Book per Share is $6.02. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Inotiv (NOTVQ), the current Cyclically Adjusted Book per Share is $6.02 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Inotiv Business Description

Other Exchanges BS50:Germany
Address 2701 Kent Avenue, West Lafayette, IN, USA, 47906
Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery, development services to the pharmaceutical, chemical, and medical device industries. It operates in two segments; Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through the DSA segment, the company supports the discovery, nonclinical development, and clinical development needs of researchers and clinicians for small molecule drug candidates, biotherapeutics, and biomedical devices. Through the RMS segment, the company offers access to a wide range of small and large research models for basic research, drug discovery, development, and specialized models for specific diseases and therapeutic areas. The company earns maximum revenue from RMS Segment.